Posted inMarket
Why Medicare Advantage Patients with Serious Illnesses Leave Plans
Discover why patients diagnosed with Alzheimer's and serious diseases are leaving Medicare Advantage plans during open enrollment and potential costs.
Posted inBusiness Insights
Suven’s High-Stakes Neuroscience Bet Enters Decisive Late-Stage Clinical Trials
Suven Life Sciences, a leading Indian biopharmaceutical innovator, has entered the final stretch of clinical development for its ambitious central nervous system (CNS) pipeline, positioning itself to address some of…
